FAVO Capital Appoints Healthcare Executive Dr. Wael Barsoum to Board of Directors

FAVO Capital (OTC: FAVO), a diversified financial company with operations in financial services and real estate, announced the appointment of Dr. Wael Barsoum to its board of directors as an independent director. Barsoum, former president and CEO of Cleveland Clinic Florida and current president and chief transformation officer at Healthcare Outcomes Performance Company, brings decades of leadership in healthcare innovation, governance, and organizational growth. This appointment represents a significant strategic move for FAVO Capital as it seeks to diversify its expertise beyond traditional financial services.

The addition of Barsoum to the board underscores FAVO Capital's commitment to building a diverse leadership team capable of guiding the company through its next phase of development. Shaun Quin, president of FAVO Capital, emphasized that Barsoum's appointment reflects the company's dedication to assembling a board with the independence, depth, and experience necessary for strategic oversight. Barsoum's extensive background in healthcare leadership and organizational transformation positions him to contribute valuable perspectives to FAVO Capital's governance structure.

FAVO Capital operates across two primary business segments: financial services and selective real assets. Through its financial services division, the company provides alternative, revenue-based funding solutions to small and mid-sized businesses throughout the United States. Since its inception, FAVO has supported more than 10,000 businesses through the purchase of future receipts, establishing itself as a significant player in the alternative lending space. The company's real assets portfolio serves to strengthen its balance sheet and broaden its collateral base, creating additional financial stability.

The strategic importance of this board appointment extends beyond mere governance enhancement. Barsoum's healthcare expertise could signal FAVO Capital's potential interest in expanding into healthcare financing or developing specialized funding solutions for medical practices and healthcare organizations. His experience in healthcare innovation and organizational growth aligns with FAVO Capital's stated commitment to financial transparency, sustainable growth, and long-term value creation for shareholders. The company maintains operations in Florida, New York, and the Dominican Republic, with its headquarters located in Fort Lauderdale, Florida.

For additional information about FAVO Capital and its latest developments, investors can access the company's newsroom at https://nnw.fm/FAVO. The full press release detailing Barsoum's appointment is available at https://nnw.fm/gLEvl. This board-level addition represents a strategic step in FAVO Capital's evolution as it continues to build its presence in both financial services and real asset management while potentially exploring new market opportunities.